New Bisabolane-Type Sesquiterpenoids from Curcuma longa and Their Anti-Atherosclerotic Activity

To explore the sesquiterpenoids in Curcuma longa L. and their activity related to anti-atherosclerosis. The chemical compounds of the rhizomes of C. longa were separated and purified by multiple chromatography techniques. Their structures were established by a variety of spectroscopic experiments. The absolute configurations were determined by comparing experimental and calculated NMR chemical shifts and electronic circular dichroism (ECD) spectra. Their anti-inflammatory effects and inhibitory activity against macrophage-derived foam cell formation were evaluated by lipopolysaccharide (LPS) and oxidized low-density lipoprotein (ox-LDL)-injured RAW264.7 macrophages, respectively. This study resulted in the isolation of 10 bisabolane-type sesquiterpenoids (1–10) from C. longa, including two pairs of new epimers (curbisabolanones A–D, 1–4). Compound 4 significantly inhibited LPS-induced nitric oxide (NO), interleukin-1β (IL-1β), interleukin-6 (IL-6), tumor necrosis factor-α (TNF-α), and prostaglandin E2 (PGE2) production in RAW264.7 cells. Furthermore, compound 4 showed inhibitory activity against macrophage-derived foam cell formation, which was represented by markedly reducing ox-LDL-induced intracellular lipid accumulation as well as total cholesterol (TC), free cholesterol (FC), and cholesterol ester (CE) contents in RAW264.7 cells. These findings suggest that bisabolane-type sesquiterpenoids, one of the main types of components in C. longa, have the potential to alleviate the atherosclerosis process by preventing inflammation and inhibiting macrophage foaming.

[1]  B. Jyotirmayee,et al.  A review on selected pharmacological activities of Curcuma longa L. , 2022, International Journal of Food Properties.

[2]  Fei Liu,et al.  Vasorelaxant effect of curcubisabolanin A isolated from Curcuma longa through the PI3K/Akt/eNOS signaling pathway. , 2022, Journal of ethnopharmacology.

[3]  J. Björkegren,et al.  Atherosclerosis: Recent developments , 2022, Cell.

[4]  Dinender K Singla,et al.  Inflammatory Cells in Atherosclerosis , 2022, Antioxidants.

[5]  G. Fredman,et al.  Atherosclerosis is a Major Human Killer and Non-resolving Inflammation is a Prime Suspect. , 2021, Cardiovascular research.

[6]  Cheng Peng,et al.  Bisabolane-type sesquiterpenoids: Structural diversity and biological activity. , 2021, Phytochemistry.

[7]  Zi-feng Yang,et al.  Bisabolane-type sesquiterpenoids from Curcuma longa L. exert anti-influenza and anti-inflammatory activities through NF-κB/MAPK and RIG-1/STAT1/2 signaling pathways. , 2021, Food & function.

[8]  M. Boskabady,et al.  Experimental and clinical reports on anti‐inflammatory, antioxidant, and immunomodulatory effects of Curcuma longa and curcumin, an updated and comprehensive review , 2021, BioFactors.

[9]  M. Borges,et al.  Absolute Configurations of Stink Bug- and Plant-Produced Sesquipiperitols via Synthesis of All Stereoisomers. , 2020, Journal of natural products.

[10]  Cheng Peng,et al.  Curcumane C and (±)-curcumane D, an unusual seco-cadinane sesquiterpenoid and a pair of unusual nor-bisabolane enantiomers with significant vasorelaxant activity from Curcuma longa. , 2019, Bioorganic chemistry.

[11]  C. Glass,et al.  Transcriptional and epigenetic regulation of macrophages in atherosclerosis , 2019, Nature Reviews Cardiology.

[12]  Ira Tabas,et al.  Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities , 2019, Nature Reviews Cardiology.

[13]  A. Anadón,et al.  Statins: Adverse reactions, oxidative stress and metabolic interactions , 2019, Pharmacology & therapeutics.

[14]  Cheng Peng,et al.  Curcumanes A and B, Two Bicyclic Sesquiterpenoids with Significant Vasorelaxant Activity from Curcuma longa. , 2019, Organic letters.

[15]  A. Sahebkar,et al.  Ethnobotany, phytochemistry and traditional uses of Curcuma spp. and pharmacological profile of two important species (C. longa and C. zedoaria): a review. , 2019, Current pharmaceutical design.

[16]  Keji Chen,et al.  Holistic Regulation of Angiogenesis with Chinese Herbal Medicines as a New Option for Coronary Artery Disease , 2018, Evidence-based complementary and alternative medicine : eCAM.

[17]  Hua Li,et al.  Chemical constituents from Curcuma longa L. and their inhibitory effects of nitric oxide production , 2018, Natural product research.

[18]  A. Hosseini,et al.  Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[19]  Guang-Lei Ma,et al.  Two New Bisabolane-Type Sesquiterpenoids from Curcuma longa , 2018 .

[20]  P. Portincasa,et al.  Cholesterol and Lipoprotein Metabolism and Atherosclerosis: Recent Advances In reverse Cholesterol Transport. , 2017, Annals of hepatology.

[21]  M. Fornage,et al.  Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association , 2017, Circulation.

[22]  Ariel M. Sarotti,et al.  Beyond DP4: an Improved Probability for the Stereochemical Assignment of Isomeric Compounds using Quantum Chemical Calculations of NMR Shifts. , 2015, The Journal of organic chemistry.

[23]  Qiang Zhang,et al.  Absolute Configurations and NO Inhibitory Activities of Terpenoids from Curcuma longa. , 2015, Journal of agricultural and food chemistry.

[24]  H. Kim,et al.  Anti-atherosclerosis and hyperlipidemia effects of herbal mixture, Artemisia iwayomogi Kitamura and Curcuma longa Linne, in apolipoprotein E-deficient mice. , 2014, Journal of ethnopharmacology.

[25]  Dean J. Tantillo,et al.  Computational prediction of 1H and 13C chemical shifts: a useful tool for natural product, mechanistic, and synthetic organic chemistry. , 2012, Chemical reviews.

[26]  Sheng Lin,et al.  Mono- and sesquiterpenoids, flavonoids, lignans, and other miscellaneous compounds of Abies georgei. , 2011, Planta medica.

[27]  F. Roussi,et al.  Biomimetic total synthesis of meiogynin A, an inhibitor of Bcl-xL and Bak interaction. , 2010, The Journal of organic chemistry.

[28]  P. Sung,et al.  Sesquiterpenes from the rhizome of Curcuma longa with inhibitory activity on superoxide generation and elastase release by neutrophils , 2010 .

[29]  K C Nicolaou,et al.  Total synthesis, revised structure, and biological evaluation of biyouyanagin A and analogues thereof. , 2008, Journal of the American Chemical Society.

[30]  Noel M. O'Boyle,et al.  cclib: A library for package‐independent computational chemistry algorithms , 2008, J. Comput. Chem..

[31]  W. Kreiser,et al.  Stereospecific Synthesis of (+)--Sesquiphellandrene , 1999 .

[32]  Eiji Ōsawa,et al.  An efficient algorithm for searching low-energy conformers of cyclic and acyclic molecules , 1993 .

[33]  A. Numata,et al.  Occurrence of epijuvabione-type sesquiterpenoids in Abies sachalinensis , 1992 .

[34]  Eiji Osawa,et al.  Corner flapping: a simple and fast algorithm for exhaustive generation of ring conformations , 1989 .

[35]  R. M. King,et al.  Germacranolides from Lychnophora species , 1982 .